Definitive Healthcare (NASDAQ:DH) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Definitive Healthcare (NASDAQ:DH) posted its quarterly earnings results on Thursday. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.04), Zacks reports. The firm had revenue of $62.29 million for the quarter, compared to analyst estimates of $60.60 million. Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. Definitive Healthcare updated its FY 2025 guidance to 0.190-0.220 EPS and its Q1 2025 guidance to 0.020-0.020 EPS.

Definitive Healthcare Price Performance

Shares of NASDAQ:DH opened at $3.23 on Friday. The company has a market cap of $373.14 million, a price-to-earnings ratio of -1.04, a PEG ratio of 4.06 and a beta of 1.45. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.49 and a quick ratio of 2.49. The firm has a 50 day simple moving average of $4.63 and a 200 day simple moving average of $4.47. Definitive Healthcare has a one year low of $2.58 and a one year high of $10.62.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on DH. Barclays reiterated an “underweight” rating and set a $4.00 price target on shares of Definitive Healthcare in a research report on Monday, January 13th. Stephens began coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price target on the stock. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $5.72.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the transaction, the insider now owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This trade represents a 9.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.84% of the stock is owned by insiders.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.